to Content

Ph.D. David MIRELMAN Professor Emeritus, Department of Biological Chemistry and Former Vice President for Technology Transfer, Weizmann Institute of Science, Rehovot

CV

 *1938 - Buenos Aires, Argentina, Immigrated to Israel 1949
1964 M.Sc. Polymer Chemistry, Hebrew University, Jerusalem
1968 Ph.D. Biochemistry of Bacterial Cell Walls, Weizmann Institute of Science, Rehovot, Israel
1968-1970 Post Doctorate, Tufts University Medical School, Boston, USA
since 1970 Faculty Member, Department of Biological Chemistry, Weizmann Institute of Science
1973 Visiting Scientist, Max-Planck-Institute, Tuebingen
1976 Associate Professor with tenure
1976-1977 University of California, Berkeley
1984 Harvard University, Cambridge, MA
1984 Full Professor, Weizmann Institute
1985 Besen-Brender Chair of Microbiology and Parasitology, Department of Biological Chemistry, Weizmann Institute of Science
1991-1992 Fogarty Scholar, National Institutes of Health, Bethesda, MD
1987-1998 Chairman of the Board of Directors, Yeda Research and Development Co. Ltd.
1989-1992 Member Board of Directors, News Datacom Corp., Jerusalem, Israel
1991-1994 Member Board of Directors, Weizmann Technological Incubator Company
1993-1998 Vice President for Technology Transfer, Weizmann Institute of Science
1995-1998 Member of Board of Directors, XTL Biotechnology, Rehovot, Israel
1996-1998 Member of Board of Directors of Portman Pharmaceuticals, Rehovot, Israel
1999-2004 Dean, Faculty of Biochemistry, Weizmann Institute of Science
1999-2001 President, Israel Society for Microbiology
2004-2012 President of Scientific Council, Conseil I.Pasteur-Weizmann I.
since 2010 Member of Executive Board of Directors, Weizmann Institute of Science

Memberships

American Society for Microbiology
American Society for Infectious Diseases
Journal of Infectious Diseases, Member of Editorial Board ( 1998-2010)
Journal of Molecular Microbiology, Member of Editorial Board (2000-2008)
Journal of Experimental Parasitology, Member of Editorial Board ( since 2005)

Publications

233 Articles in Peer Reviewed International Journals, 6 Patents, 2 Books
Targeted Allicin as anti-tumor, Molecular Cancer Therapy 4, 325, 2005
Multiple gene silencing in amoeba, PLoS Pathogens 2, 431, 2006
3D structure of Alliinase with PLP, Journal of Molecular Biology 16, 366, 2007
Epigenetic gene silencing in amoeba, IUBMB-Life, May, 2008

Awards

Fogarty Scholar Medal Award, National Institutes of Health, 1993
Serov Prize, Israel Society for Microbiology, 1994
Landau Prize in Biological Sciences, 1995
Inventor of the Year, Yeda Research and Development Co. Ltd., 2005